BI
Biogen Inc
🇩🇪XFRA.IDPGermanyHealthcare
€185.16EURdown -3.00 (-1.59%)ClosedEnd of day9:48 PM
Price€185.16-3.00 (-1.59%)
Profile
- Healthcare
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US09062X1037
- CUSIP
- Not reported
Company
- Employees
- 7,500
- Headquarters
- Cambridge, United States
- Website
- https://www.biogen.com
- CEO
- Mr. Christopher A. Viehbacher
Market
- Shares outstanding
- 146.7M
- Market cap
- €27.16B
Highlights
- Market cap
- €27.16B
- EPS LTM
- $5.69calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $9.95B-0.49%down year on year
- Net income
- $835.09M-45.44%down year on year
- Gross margin
- 67.71%-6.65%down year on year
- Free cash flow
- $2.97B+59.89%up year on year
Other listings
- XSTU.IDPStuttgart Stock Exchange
- XNAS.BIIBNasdaq
- XETR.IDPXetra
- XMEX.BIIBMexican Stock Exchange
- BVMF.BIIB34B3 - Brasil Bolsa Balcão
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.